Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 12-2016 | |
| Sales | 191 | 0 | 159 | 0 | 0 |
| Gross Profit | 191 | N/A | 159 | N/A | N/A |
| Operating Expenses | 12,394 | 0 | 8,455 | 6,413 | 0 |
| Operating Income | -12,203 | N/A | -8,296 | -6,413 | N/A |
| Other Income | 146 | 0 | 213 | 211 | 0 |
| Pre-tax Income | -12,057 | 0 | -8,083 | -6,202 | 0 |
| Income Tax | 89 | N/A | 88 | 78 | N/A |
| Net Income Continuous | -12,146 | N/A | -8,171 | -6,280 | N/A |
| Net Income | $-12,146 | $N/A | $-8,171 | $-6,280 | $N/A |
| EPS Basic Total Ops | -919.94 | N/A | -662.07 | -591.30 | N/A |
| EPS Basic Continuous Ops | -919.93 | N/A | -662.04 | -591.33 | N/A |
| EPS Diluted Total Ops | -919.94 | N/A | -662.07 | -591.30 | N/A |
| EPS Diluted Continuous Ops | -919.93 | N/A | -662.04 | -591.33 | N/A |
| EBITDA(a) | $-12,172 | $N/A | $-8,274 | $-6,413 | $N/A |